Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Achievement and JAK2[original query]
New real-time PCR-based method for the joint genotyping of JAK2 (V617F) with inherited thrombophilic F5 and F2 mutations.
Clinica chimica acta; international journal of clinical chemistry 2009 Dec 410 (1-2): 59-63.
Martínez-Serra J, Maffiotte E, Gutierrez A, Durán M A, Amat J C, Besalduch
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.
Blood 2010 Nov 116 (18): 3572-81.
Alchalby Haefaa, Badbaran Anita, Zabelina Tatjana, Kobbe Guido, Hahn Joachim, Wolff Daniel, Bornhäuser Martin, Thiede Christian, Baurmann Herrad, Bethge Wolfgang, Hildebrandt York, Bacher Ulrike, Fehse Boris, Zander Axel R, Kröger Nicola
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood 2013 Jan 121 (1): 170-7.
Paschka Peter, Du Juan, Schlenk Richard F, Gaidzik Verena I, Bullinger Lars, Corbacioglu Andrea, Späth Daniela, Kayser Sabine, Schlegelberger Brigitte, Krauter Jürgen, Ganser Arnold, Köhne Claus-Henning, Held Gerhard, von Lilienfeld-Toal Marie, Kirchen Heinz, Rummel Mathias, Götze Katharina, Horst Heinz-August, Ringhoffer Mark, Lübbert Michael, Wattad Mohammed, Salih Helmut R, Kündgen Andrea, Döhner Hartmut, Döhner Konstan
[Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways].
Terapevticheskii arkhiv 2020 12 92 (7): 31-42.
Zarubina K I, Parovichnikova E N, Surin V L, Pshenichnikova O S, Gavrilina O A, Isinova G A, Troitskaia V V, Sokolov A N, Gal'tseva I V, Kapranov N M, Davydova I O, Obukhova T N, Sudarikov A B, Savchenko V
Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapy.
British journal of haematology 2024 10 .
Tiziano Barbui, Alessandra Carobbio, Paola Guglielmelli, Arianna Ghirardi, Francesca Fenili, Giuseppe Gaetano Loscocco, Valerio De Stefano, Francesco Ramundo, Maria Chiara Finazzi, Alessandro Rambaldi, Alessandro M Vannucc
TOP